Pepcid Marketing Strategy To Stay Unchanged In Face Of Prilosec 1 Launch
This article was originally published in The Tan Sheet
Executive Summary
J&J/Merck has no plans to change the marketing strategy behind its Pepcid line of heartburn products, despite the probable upcoming launch of an OTC version of Prilosec